News

  • Length does matter – looking at micro-RNAs to predict cancer and disease

    A world-first study has shown ‘length does matter’ when using small molecules called microRNAs as potential biomarkers to detect and predict cancer and inflammatory diseases. The study, published in the journal RNA, was led by Dr Michael Gantier and PhD student Ms Charlotte Nejad at Hudson Institute, together with collaborators from Monash University, Royal College…  Read more

  • Hudson Institute student a FameLab semi-finalist

    PhD student, Aidan Kashyap has been selected as a FameLab semi-finalist for his research that is offering hope for babies who struggle to breathe at birth due to underdeveloped lungs. Aidan will compete against 11 other STEM early career researchers in the FameLab Victorian semi-finals at the Melbourne Museum on Wednesday, 28 March 2018. FameLab,…  Read more

  • Hudson Institute enters into research alliance with Invion Limited

    Hudson Institute has entered into a Research and Development Alliance Agreement with Invion Limited to provide key scientific assessment of Invion’s cancer treatment technology, Photosoft. The collaboration will initially focus on the treatment of ovarian cancer, with a view to expanding research and development projects into other forms of cancer. Hudson Institute will provide the…  Read more

  • Dr Sue Fowler Scholarship in Ovarian Cancer awarded to Mrs Nazanin Karimnia

    The inaugural Dr Sue Fowler Scholarship in Ovarian Cancer has been awarded to PhD student, Mrs Nazanin Karimnia to support her research into new ovarian cancer therapies. The scholarship was established in honour of the late Dr Sue Fowler, to support a Hudson Institute PhD student undertaking research into ovarian cancer. There is an urgent…  Read more

  • Endometriosis case study, Jasmine enjoying the sunshine in a park

    Jasmine’s story

    Jasmine started experiencing severe period pain as a teenager and endured five years of pain before she was diagnosed with endometriosis. Her journey continues.…  Read more

  • Prof Phil Bardin

    High-dose steroids don’t prevent asthma flare-ups

    High doses of glucocorticoids are not effective in preventing life-threatening asthma flare-ups, according to a landmark study published in The New England Journal of Medicine (NEJM). Glucocorticoids are anti-inflammatory medications used in many everyday prescription asthma puffers, such as turbuhalers or accuhalers. Hudson Institute research group head, Professor Phil Bardin was invited by the NEJM…  Read more

  • Endometriosis Case Study Evelyn

    Evelyn’s story | infiltrating bowel endometriosis

    ‘Invisible illness’ took years of pain and a trip to the emergency ward before diagnosis. It wasn’t until Evelyn’s debilitating symptoms started to impact her daily life that she sought help – but that was only the beginning of her journey.…  Read more

  • Bianca Endometriosis Sufferer

    Bianca’s story: from silent endometriosis to advocate

    Bianca had the worst case of endometriosis her doctors said they had seen. Yet, she had no pelvic pain and was only diagnosed after experiencing infertility. She now wants to raise awareness so that other women don’t suffer.…  Read more

  • Preventing gestational diabetes

    Early career researchers Dr Stacey Ellery and Ms Aya Mousa have won the MHTP Research Week ECR speed networking event, receiving a $10,000 grant to progress their research idea.…  Read more

  • Finding the right treatment for repeated implantation failure

    Uncovering how abnormal immune cell populations in the womb could be linked to repeat implantation failure and early pregnancy loss is the focus of new research by Dr Ellen Menkhorst. Dr Menkhorst, a Research Scientist in the Embryo Implantation Research Group, has been awarded a $100,000 grant from the Rebecca L. Cooper Foundation to help…  Read more

Hudson News

Get the inside view on discoveries and patient stories

Stay connected